Nanoscale biotechnology lab

Engineering new protein scaffolds and binders to precisely regulate cellular pathways. Developing epigenetic modulators amplify cryptic molecular signals (e.g., rare methylation marks, splicing variants). Profiling molecular states to predict disease risk before symptoms appear. Integrating biomarker readouts into preventive and proactive health-care models. Developing pipelines to link omics to actionable care pathways. Feeding real-world patient signals back into discovery to refine molecular designs. Building functional profiling platforms that validate interventions in complex biological systems. Closing the loop from clinic → lab → clinic, accelerating translation.